Even as President Donald Trump paused the reciprocal tariffs for 90 days on Wednesday, he later conf...
Regeneron Pharmaceuticals (NASDAQ:REGN) Reaches New 1-Year Low - What's Next?...
Epithelioma Treatment Market Forecast and Company Analysis Report 2025-2034: Amgen, AstraZeneca, BeiGene, BMS, F. Hoffmann-La Roche, J&J, Merck, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Epithelioma Treatment Market Opportunity, Growth Dri...
Renaissance Technologies LLC increased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NA...
FIL Ltd grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) b...